Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Graham

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Diabetes Technology & Therapeutics|June 7, 2017
Continuous Glucose Monitoring and Global Reimbursement: An UpdateClaudia Graham
Journal of Diabetes Science and Technology|February 17, 2016
The Potential Cost Implications of Averting Severe Hypoglycemic Events Requiring Hospitalization in High-Risk Adults With Type 1 Diabetes Using Real-Time Continuous Glucose MonitoringAmy Bronstone, Claudia Graham
Journal of Medical Economics|July 27, 2017
Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspectiveShraddha Chaugule, Claudia Graham
Journal of Diabetes Science and Technology|July 27, 2017
Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care UtilizationChristopher G Parkin, Claudia Graham, John Smolskis
European Endocrinology|April 11, 2018
An Economic Evaluation of Continuous Glucose Monitoring for People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia within North West London Clinical Commissioning Groups in EnglandShraddha Chaugule, Nick Oliver, Brigitte Klinkenbijl, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 28, 2009
A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party US payer perspectiveMeaghan St Charles, Peter Lynch, Claudia Graham, et al.
Journal of Diabetes Science and Technology|October 1, 2015
Are Systematic Reviews and Meta-Analyses Appropriate Tools for Assessing Evolving Medical Device Technologies?David Price, Claudia Graham, Christopher G Parkin, et al.
Journal of Diabetes Science and Technology|April 29, 2017
Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND TrialKatrina J Ruedy, Christopher G Parkin, Tonya D Riddlesworth, et al.
Journal of Diabetes Science and Technology|March 12, 2015
HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily InjectionsLutz Heinemann, Dorothee Deiss, Norbert Hermanns, et al.
Journal of Diabetes Science and Technology|February 5, 2016
The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 DiabetesStephanie J Fonda, Claudia Graham, Julie Munakata, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Diabetes Technology & Therapeutics|June 7, 2017
Continuous Glucose Monitoring and Global Reimbursement: An UpdateClaudia Graham
Journal of Diabetes Science and Technology|February 17, 2016
The Potential Cost Implications of Averting Severe Hypoglycemic Events Requiring Hospitalization in High-Risk Adults With Type 1 Diabetes Using Real-Time Continuous Glucose MonitoringAmy Bronstone, Claudia Graham
Journal of Medical Economics|July 27, 2017
Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspectiveShraddha Chaugule, Claudia Graham
Journal of Diabetes Science and Technology|July 27, 2017
Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care UtilizationChristopher G Parkin, Claudia Graham, John Smolskis
European Endocrinology|April 11, 2018
An Economic Evaluation of Continuous Glucose Monitoring for People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia within North West London Clinical Commissioning Groups in EnglandShraddha Chaugule, Nick Oliver, Brigitte Klinkenbijl, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 28, 2009
A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party US payer perspectiveMeaghan St Charles, Peter Lynch, Claudia Graham, et al.
Journal of Diabetes Science and Technology|October 1, 2015
Are Systematic Reviews and Meta-Analyses Appropriate Tools for Assessing Evolving Medical Device Technologies?David Price, Claudia Graham, Christopher G Parkin, et al.
Journal of Diabetes Science and Technology|April 29, 2017
Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND TrialKatrina J Ruedy, Christopher G Parkin, Tonya D Riddlesworth, et al.
Journal of Diabetes Science and Technology|March 12, 2015
HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily InjectionsLutz Heinemann, Dorothee Deiss, Norbert Hermanns, et al.
Journal of Diabetes Science and Technology|February 5, 2016
The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 DiabetesStephanie J Fonda, Claudia Graham, Julie Munakata, et al.
Pageof 2